Read the latest positive news, breakthroughs, and inspiring stories about pediatric research, curated daily by BrightWire.
A breakthrough study reveals why a new treatment for Duchenne muscular dystrophy helps young boys gain strength without stunting their growth, unlike traditional steroids. Blood tests show the safer drug preserves bone and cartilage health while delivering the same muscle benefits.
Boys as young as 2 with Duchenne muscular dystrophy showed remarkable improvements in just 12 weeks when treated early with a safer alternative to steroids. Researchers say starting treatment before symptoms appear could protect muscles before they're lost forever.
A groundbreaking study of 900 childhood cancer survivors shows that dexrazoxane dramatically reduces heart damage from chemotherapy for over 15 years after treatment ends. The discovery could mean fewer heart tests and more peace of mind for young cancer survivors and their families.
